한글목차

세계 무바늘 기기 시장 규모는 2024년 155억 달러, 2025년 170억 달러에서 2025-2030년 10.2%의 연평균 복합 성장률(CAGR)로 성장하여 2030년에는 277억 달러에 달할 것으로 예측됩니다.

북미 시장은 2024년 67억 달러, 2025년 74억 달러에서 2025-2030년 연평균 10.4% 성장하여 2030년에는 121억 달러에 달할 것으로 예측됩니다. 아시아태평양 시장은 2024년 25억 달러, 2025년 28억 달러에서 연평균 12.1% 성장하여 2030년에는 50억 달러에 이를 것으로 예측됩니다.

세계의 무바늘 기기 시장을 조사했으며, 시장 개요, 시장 영향요인 및 시장 기회 분석, 시장 규모 추이 및 예측, 각종 부문별/지역별 상세 분석 등의 정보를 정리하여 전해드립니다.

목차

제1장 주요 요약

• 시장 전망
• 조사 범위
• 시장 요약

제2장 시장 개요

• 개요
• 거시경제 요인
• 미국 관세가 의약품 및 의료기기 업계에 미치는 영향
• 인구통계와 고령화
• 의료 인프라와 지출
• 규제와 정책 상황
• 기술 진보와 자금조달
• 지정학적 리스크, 무역 전쟁, 공급망 혼란
• Porter의 Five Forces 분석

제3장 시장 역학

• 개요
• 시장 성장 촉진요인
• 시장 성장 억제요인
• 시장 기회

제4장 규제 상황

• 개요
• 미국 규제 시나리오
• 유럽 규제 시나리오
• 일본 규제 시나리오
• 중국 규제 시나리오
• FDA 승인 흡입기
• FDA 승인 경피 패치

제5장 새로운 동향과 파이프라인 분석

• 새로운 동향
• 스마트 패치
• 스마트 흡입기
• Sonophoresis
• 3D 프린팅 마이크로어레이 패치
• 용해성/분해성 패치
• 파이프라인 분석
• 요약
• 특허 분석
• 흡입기 기술
• 경피패치
• 무바늘 주사기
• 조사 결과

제6장 시장 세분화 분석

• 세분화 내역
• 시장 분석 : 제품 유형별
• 요약
• 흡입기 기술
• 경피 패치
• 무바늘 주사기
• 기타
• 시장 분석 : 용도별
• 요약
• 백신
• 통증 관리
• 인슐린 투여
• 소아 약물전달
• 기타
• 시장 분석 : 최종사용자별
• 요약
• 병원 및 진료소
• 가정치료 환경
• 연구 및 학술기관
• 지역 분석
• 시장 분석 : 지역별
• 중요 포인트
• 북미
• 유럽
• 아시아태평양
• 남미
• 중동 및 아프리카

제7장 경쟁 정보

• 요약
• 주요 기업의 시장 점유율
• 전략 분석

제8장 무바늘 기기의 지속가능성 : ESG 관점

• 개요
• 환경 지속가능성
• 사회적 책임
• 거버넌스 관점
• ESG 리스크 평가
• BCC의 결론

제9장 부록

• 조사 방법
• 출전
• 약어
• 기업 개요
• AKRA DERMOJET
• APTARGROUP INC.
• ARX LLC.
• ASTRAZENECA
• AVAXZIPEN
• CROSSJECT
• ENDO INC.
• GSK PLC.
• HALOZYME INC.
• MIKA MEDICAL CO.
• NOVARTIS AG
• NUGEN MEDICAL DEVICES
• PHARMAJET
• PRESSPART VERWALTUNGS GMBH
• VIATRIS INC.
• 신흥 스타트업 기업/시장 디스럽터

영문목차

The global market for needle-free devices was valued at $15.5 billion in 2024 and is estimated to increase from $17.0 billion in 2025 to reach $27.7 billion by 2030, at a compound annual growth rate (CAGR) of 10.2% from 2025 through 2030.

The North American market for needle-free devices was valued at $6.7 billion in 2024 and is estimated to increase from $7.4 billion in 2025 to reach $12.1 billion by 2030, at a CAGR of 10.4% from 2025 through 2030.

The Asia-Pacific market for needle-free devices was valued at $2.5 billion in 2024 and is estimated to increase from $2.8 billion in 2025 to reach $5.0 billion by 2030, at a CAGR of 12.1% from 2025 through 2030.

Report Scope

Both qualitative and quantitative data on the current market dynamics and trends are presented in this report on the global market for needle-free devices. The report also assesses recent technological developments and product performance. Analyses of the most popular products, clinical trials, new product approvals, and emerging technologies are also included. The market prospects for five regions-North America, Europe, Asia-Pacific, South America, and the Middle East and Africa (MEA)-are discussed. The report also includes profiles of leading companies and their strategies.

The global market is segmented into the following product types: needle-free injectors, inhaler technologies, transdermal patch technologies and other novel technologies. By application, the market is segmented into vaccines, pain management, insulin delivery, pediatric injections and others. By end-user, the market is segmented into hospitals and clinics, homecare settings, and research and academic institutions. For market estimates, data has been provided for 2024 as the base year, with forecasts for 2025 through 2030.

Report Includes

• 49 data tables and 56 additional tables
• An overview of the global market for needle-free devices and technologies
• Analyses of global market trends with data from 2022 to 2025 and projected CAGRs through 2030
• Highlights of the current and future market potential and quantification of the market by product type, application, end user and region
• Assessment of the recent developments, key technological updates and product performance within the needle-free devices market
• Insight into various needle-free technologies that are used in drug delivery and their application areas
• Discussion of government regulations that can affect the global needle-free devices market
• Identification of challenges and discussion on how to overcome those to reach its commercialization potential, and ESG trends of the market
• Market share analysis of the key companies of the industry and coverage of their proprietary technologies, strategic alliances, and other key market strategies and a relevant patent analysis
• Company profiles of major players within the industry, including GSK plc., Novartis AG, Viatris Inc., and PharmaJet

Table of Contents

Chapter 1 Executive Summary

• Market Outlook
• Scope of Report
• Market Summary

Chapter 2 Market Overview

• Overview
• Macroeconomic Factors
• Impact of U.S. Tariffs on the Pharmaceutical and Medical Device Industries
• Population Demographics and Aging Populations
• Healthcare Infrastructure and Spending
• Regulatory and Policy Landscape
• Technological Advances and Funding
• Geopolitical Risks, Trade Wars, and Supply Chain Disruptions
• Porter's Five Forces Analysis
• Potential for New Entrants (Moderate to High)
• Bargaining Power of Suppliers (Low to Moderate)
• Bargaining Power of Buyers (Moderate to High)
• Threat of Substitute Products or Services (High)
• Industry Level of Competitiveness (Moderate to High)

Chapter 3 Market Dynamics

• Overview
• Market Drivers
• Increasing Incidence of Needlestick Injuries
• Preference for Painless Drug Delivery
• Demand for Home Healthcare and Self-Administration
• Market Restraints
• Cost of Needle-Free Technology
• Limitations of Large Volume and Intravenous Administration Systems
• Market Opportunities
• Product Innovation
• Increased Investments in Healthcare in Emerging Markets

Chapter 4 Regulatory Landscape

• Overview
• Regulatory Scenario in the U.S.
• Regulatory Scenario in Europe
• Regulatory Scenario in Japan
• Regulatory Scenario in China
• FDA-Approved Inhalers
• FDA-Approved Transdermal Patch

Chapter 5 Emerging Trends and Pipeline Analysis

• Emerging Trends
• Smart Patches
• Smart Inhalers
• Sonophoresis
• 3D-Printed Microarray Patches
• Dissolving/Degradable Patches
• Pipeline Analysis
• Takeaways
• Patent Analysis
• Inhaler Technologies
• Transdermal Patches
• Needle-Free Injectors
• Findings

Chapter 6 Market Segmentation Analysis

• Segmentation Breakdown
• Market Breakdown by Product Type
• Takeaways
• Inhaler Technologies
• Transdermal Patches
• Needle-free Injectors
• Other Novel Technologies
• Market Breakdown by Application
• Takeaways
• Vaccines
• Pain Management
• Insulin Delivery
• Pediatric Drug Delivery
• Other Applications
• Market Breakdown by End-User
• Takeaways
• Hospital and Clinics
• Homecare Settings
• Research and Academic Institutions
• Geographic Breakdown
• Market Breakdown by Region
• Key Takeaways
• North America
• Europe
• Asia-Pacific
• South America
• Middle East and Africa

Chapter 7 Competitive Intelligence

• Takeaways
• Market Shares of Leading Companies
• Strategic Analysis

Chapter 8 Sustainability in Needle-Free Devices: ESG Perspective

• Overview
• Environmental Sustainability
• Social Responsibility
• Governance Perspective
• ESG Risk Ratings
• Concluding Remarks from BCC Research

Chapter 9 Appendix

• Research Methodology
• Sources
• Abbreviations
• Company Profiles
• AKRA DERMOJET
• APTARGROUP INC.
• ARX LLC.
• ASTRAZENECA
• AVAXZIPEN
• CROSSJECT
• ENDO INC.
• GSK PLC.
• HALOZYME INC.
• MIKA MEDICAL CO.
• NOVARTIS AG
• NUGEN MEDICAL DEVICES
• PHARMAJET
• PRESSPART VERWALTUNGS GMBH
• VIATRIS INC.
• Emerging Start-ups/Market Disruptors